Substance active (DCI)
- guanfacine (chlorhydrate)
Informations techniques
Exploitant
Laboratoire NOVARTIS PHARMA
Présentation
ESTULIC 2 mg, comprimé
B/30 : CIP 323 305-8
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
PxpPXAG4SJJ0BMp0